Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 52.96% institutional investors, 1.40% insiders, and 45.65% retail investors. Bvf inc/il is the largest institutional shareholder, holding 8.16% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.08% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eledon Pharmaceuticals	52.96%	1.40%	45.65%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	6.29M	8.16%	$17.05M
Vanguard group	2.89M	5.57%	$11.93M
Ra capital management	3.57M	4.62%	$9.66M
Blackrock funding, inc. /de	3.25M	4.22%	$8.82M
First light asset management	2.60M	3.37%	$7.05M
Woodline partners lp	1.67M	3.22%	$6.89M
Schonfeld strategic advisors	1.52M	2.92%	$6.24M
Sphera funds management	1.96M	2.54%	$5.31M
Blue owl capital lp	1.33M	1.72%	$3.60M
Ensign peak advisors	1.26M	1.64%	$3.43M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sanofi	814.98K	1.26%	$2.21M
Sphera funds management	1.96M	1.25%	$5.31M
Blue owl capital lp	1.33M	1.16%	$3.60M
Velan capital investment management lp	323.97K	1.13%	$1.10M
22nw, lp	636.36K	1.09%	$1.72M
Cm management	275.00K	1.01%	$1.13M
First light asset management	2.60M	0.91%	$7.05M
Bvf inc/il	6.29M	0.61%	$17.05M
Ikarian capital	1.00M	0.52%	$2.71M
Exome asset management	114.14K	0.34%	$386.95K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	3.25M	0.00%	2.60M
Vanguard group	2.89M	0.00%	1.33M
Woodline partners lp	1.67M	0.05%	828.93K
Millennium management	810.88K	0.00%	692.01K
Ubs group	318.58K	0.00%	318.58K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-2.36M
Frazier life sciences management	-	-	-1.18M
Point72 asset management	-	-	-1.09M
Blue owl capital lp	1.33M	1.16%	-490.00K
Sphera funds management	1.96M	1.25%	-347.51K

New Positions

Holder	Shares	% Assets	Change	Value
Inspire investing	194.69K	0.09%	194.69K	$802.12K
Goldman sachs group	144.84K	0.00%	144.84K	$596.76K
Barclays	70.00K	0.00%	70.00K	$288.00K
Citigroup	66.90K	0.00%	66.90K	$275.63K
American century companies	35.59K	0.00%	35.59K	$96.45K

Sold Out

Holder	Change
Jpmorgan chase	-97.00
Ifs advisors	-100.00
Wells fargo & company/mn	-189.00
Jones financial companies lllp	-725.00
Citadel advisors	-1.40K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	88	2.33%	40,843,213	6.23%	52	2.13%	48	37.14%	16	-23.81%
Mar 31, 2025	14	-81.82%	17,746,490	-53.88%	29	0.54%	4	-93.75%	4	100.00%
Dec 31, 2024	17	-48.48%	4,377,486	-76.32%	8	0.67%	12	-	-	-100.00%
Sep 30, 2024	33	6.45%	18,485,827	1.24%	35	0.96%	12	-42.86%	6	500.00%
Jun 30, 2024	31	3.33%	18,259,810	90.30%	60	3.88%	21	90.91%	1	-85.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.84M	3.08%	-40.65K
iShares Russell 2000 ETF	1.26M	2.10%	-23.84K
Vanguard US Total Market Shares ETF	1.15M	1.92%	-
Vanguard Institutional Extnd Mkt Idx Tr	669.79K	1.12%	-305.20K
iShares Russell 2000 Value ETF	473.85K	0.79%	352.00
Fidelity Extended Market Index	325.25K	0.54%	-849.00
MEDICAL BioHealth EUR Acc	294.49K	0.49%	-
Vanguard Russell 2000 ETF	278.86K	0.47%	-19.43K
State St Russell Sm Cap® Indx SL Cl I	206.80K	0.35%	-
Inspire Fidelis Multi Factor ETF	187.76K	0.31%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$440.49
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.10K
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.21K
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$1.95M
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$232.07

Insider Transactions Trends

Date	Buy	Sell
2035 Q1	-	-
2025 Q1	-	-
2024 Q4	3	-
2024 Q2	6	-
2023 Q4	-	-

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 52.96%, followed by 1.40% insiders and 45.64% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Eledon Pharmaceuticals falls below.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 8.16%), Vanguard group (2.89M shares, 5.57%), and Ra capital management (3.57M shares, 4.62%). Together, they hold 18.36% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sanofi is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.26% of its assets in 814.98K Eledon Pharmaceuticals shares, valued at 2.21M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.08% of its total shares outstanding invested in 1.84M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools